af-002 (PSW-1025)
Prostate Cancer (Refractory)
IND-enablingActive
Key Facts
About Alpha Fusion
A Japanese biotech developing targeted alpha therapies using Astatine-211 for precise cancer treatment with minimal side effects.
View full company profile